Literature DB >> 1936722

Evaluation of cost-effectiveness research: a survey of recent publications.

T G Ganiats1, A F Wong.   

Abstract

Because of interest in cost containment, a series of basic guidelines for performing cost-effectiveness research has evolved in the past decade. These guidelines advise that the perspective of the cost study be clarified, that all applicable costs, benefits, and health outcomes be included, and that discounting and sensitivity analyses be performed where appropriate. A survey of 47 recent cost-effectiveness publications selected via MEDLINE and manual searches confirms our hypothesis that many studies do not adhere to these guidelines. Since such short-comings can lead to misleading or ill-founded conclusions, attention must be paid to the principles of cost-effectiveness research to avoid making major, inappropriate health policy decisions.

Mesh:

Year:  1991        PMID: 1936722

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  5 in total

Review 1.  Why training is the key to successful guideline implementation.

Authors:  A D Paltiel; P J Neumann
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

2.  On sale: future health care. The paradox of discounting.

Authors:  T G Ganiats
Journal:  West J Med       Date:  1992-05

Review 3.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies.

Authors:  J A Barber; S G Thompson
Journal:  BMJ       Date:  1998-10-31

4.  Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention.

Authors:  D R Holtgrave; J A Kelly
Journal:  Am J Public Health       Date:  1996-10       Impact factor: 9.308

Review 5.  Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.

Authors:  Donatus U Ekwueme; Leonardo A Stroud; Yanjing Chen
Journal:  Prev Chronic Dis       Date:  2007-09-15       Impact factor: 2.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.